At BioNet, we’ve led the charge in developing and manufacturing innovative vaccines, particularly our Recombinant Pertussis Vaccines (RPV). These vaccines, including the breakthrough Recombinant Pertussis-Only vaccine, and Td-Pertussis vaccine, offer life-saving protection, especially for pregnant women. Currently licensed in Asia, RPV is part of Thailand’s maternal immunization program, and regulatory submissions have been made to the European Medicines Agency (EMA) and Australia’s TGA. Our cutting-edge vaccines are transforming pertussis prevention, ensuring better protection for individuals across all stages of life.

Additionally, we distribute a wide selection of vaccines, including Influenza, Polio, Rabies, and Hepatitis A, ensuring comprehensive immunization options. Explore how our products are shaping a healthier future for everyone.